ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,998Medicare Part D Prescriptions Filled, Including Refills

Rank: 180 out of 783

$661K Total Retail Price of All Prescriptions

Rank: 158 out of 783

588 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 588 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 588 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 9,639 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
AMLODIPINE BESYLATE 622 620 1 5
SIMVASTATIN 510 501 2 3
LEVOTHYROXINE SODIUM 401 379 3 1
LISINOPRIL 325 296 4 4
ATORVASTATIN CALCIUM 274 262 5 11
OMEPRAZOLE 238 234 6 6
CRESTOR 218 218 7 27
LOSARTAN POTASSIUM 212 212 8 18
ALENDRONATE SODIUM 201 199 9 25
HYDROCHLOROTHIAZIDE 200 192 10 12
METOPROLOL SUCCINATE 199 198 11 13
FUROSEMIDE 178 173 12 7
METFORMIN HCL 158 152 13 8
ZOLPIDEM TARTRATE 150 144 14 23
FLUOXETINE HCL 150 150 14 45
HYDROCODONE-ACETAMINOPHEN 137 137 S3 16 2
SERTRALINE HCL 131 130 17 22
SYNTHROID 128 128 18 47
MELOXICAM 126 108 19 37
METOPROLOL TARTRATE 122 117 20 9
GABAPENTIN 117 113 21 15
TRIAMTERENE-HCTZ 117 110 21 42
POTASSIUM CHLORIDE 116 116 23 16
TAMSULOSIN HCL 115 107 24 26
ALLOPURINOL 91 91 25 31
FLUTICASONE PROPIONATE 90 90 26 46
DIOVAN 89 89 27 49
PREDNISONE 88 87 28 36
ATENOLOL 88 85 28 17
CIPROFLOXACIN HCL 86 82 30 62
PRAVASTATIN SODIUM 85 81 31 14
TRAMADOL HCL 83 83 32 20
METFORMIN HCL ER 79 79 33 64
CITALOPRAM HBR 79 79 33 19
WARFARIN SODIUM 78 78 35 10
LOSARTAN-HYDROCHLOROTHIAZIDE 74 74 36 53
AZITHROMYCIN 73 73 37 41
NAMENDA 71 71 38 32
AMITRIPTYLINE HCL 69 69 R 39 77
DONEPEZIL HCL 67 67 40 24
INDAPAMIDE 66 66 41 246
EVISTA 65 65 42 92
CELEBREX 65 65 42 93
ZETIA 63 63 44 80
CLOPIDOGREL 62 62 45 29
VERAPAMIL ER 62 62 45 119
GLIMEPIRIDE 60 60 47 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 54 48 33
VENLAFAXINE HCL 53 47 49 233
VENLAFAXINE HCL ER 52 41 50 100
NEXIUM 50 50 51 28
FENOFIBRATE 50 50 51 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.